Literature DB >> 8198043

Pravastatin, lipids, and major coronary events.

C D Furberg1, R P Byington, J R Crouse, M A Espeland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8198043     DOI： 10.1016/0002-9149(94)90297-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  11 in total

1.  Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke.

Authors:  S Warshafsky; D Packard; S J Marks; N Sachdeva; D M Terashita; G Kaufman; K Sang; A J Deluca; S J Peterson; W H Frishman
Journal:  J Gen Intern Med       Date:  1999-12       Impact factor: 5.128

2.  Debate: Are surrogate end-point studies worth the effort?

Authors:  Jonathan Valabhji; Robert S Elkeles
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000

3.  Lower patients' cholesterol now.

Authors:  M Oliver; P Poole-Wilson; J Shepherd; M J Tikkanen
Journal:  BMJ       Date:  1995-05-20

Review 4.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

5.  Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischaemic dog hearts.

Authors:  K Satoh; A Yamato; T Nakai; K Hoshi; K Ichihara
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

6.  Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients.

Authors:  Peter Willeit; Lena Tschiderer; Michael J Sweeting; Simon G Thompson; Matthias W Lorenz; Elias Allara; Kathrin Reuber; Lisa Seekircher; Lu Gao; Ximing Liao; Eva Lonn; Hertzel C Gerstein; Salim Yusuf; Frank P Brouwers; Folkert W Asselbergs; Wiek van Gilst; Sigmund A Anderssen; Diederick E Grobbee; John J P Kastelein; Frank L J Visseren; George Ntaios; Apostolos I Hatzitolios; Christos Savopoulos; Pythia T Nieuwkerk; Erik Stroes; Matthew Walters; Peter Higgins; Jesse Dawson; Paolo Gresele; Giuseppe Guglielmini; Rino Migliacci; Marat Ezhov; Maya Safarova; Tatyana Balakhonova; Eiichi Sato; Mayuko Amaha; Tsukasa Nakamura; Kostas Kapellas; Lisa M Jamieson; Michael Skilton; James A Blumenthal; Alan Hinderliter; Andrew Sherwood; Patrick J Smith; Michiel A van Agtmael; Peter Reiss; Marit G A van Vonderen; Stefan Kiechl; Gerhard Klingenschmid; Matthias Sitzer; Coen D A Stehouwer; Heiko Uthoff; Zhi-Yong Zou; Ana R Cunha; Mario F Neves; Miles D Witham; Hyun-Woong Park; Moo-Sik Lee; Jang-Ho Bae; Enrique Bernal; Kristian Wachtell; Sverre E Kjeldsen; Michael H Olsen; David Preiss; Naveed Sattar; Edith Beishuizen; Menno V Huisman; Mark A Espeland; Caroline Schmidt; Stefan Agewall; Ercan Ok; Gülay Aşçi; Eric de Groot; Muriel P C Grooteman; Peter J Blankestijn; Michiel L Bots
Journal:  Circulation       Date:  2020-06-17       Impact factor: 29.690

Review 7.  Choosing the most appropriate treatment for stable angina. Safety considerations.

Authors:  S Asirvatham; C Sebastian; U Thadani
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606

Review 8.  Statins in the treatment of chronic heart failure: a systematic review.

Authors:  Pim van der Harst; Adriaan A Voors; Wiek H van Gilst; Michael Böhm; Dirk J van Veldhuisen
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

Review 9.  The role of statins in the prevention of preeclampsia.

Authors:  Devin D Smith; Maged M Costantine
Journal:  Am J Obstet Gynecol       Date:  2020-08-17       Impact factor: 8.661

10.  All cholesterol-lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT.

Authors:  Raffaele De Caterina; Tanya Salvatore; Roberto Marchioli
Journal:  Data Brief       Date:  2016-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.